GB Sciences (GBLX) News Today → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free GBLX Stock Alerts $0.0099 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 12, 2024 | bbc.comGB News posts £42m loss but grows online audienceDecember 14, 2023 | finance.yahoo.comGb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)November 2, 2023 | dailymail.co.ukTeam GB News: Medals and Schedule at Winter OlympicsOctober 8, 2023 | mirror.co.ukDan Wootton's replacement on GB News revealed as he's suspended over Laurence Fox rantOctober 6, 2023 | mirror.co.ukGB News boss explains why Dan Wootton is still on air amid allegations against presenterOctober 3, 2023 | mirror.co.ukGB News suspends third presenter for supporting Dan Wootton in Laurence Fox rowOctober 2, 2023 | dailymail.co.ukGB News - Updates on the British television news channelJuly 11, 2023 | finance.yahoo.comGb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of LethbridgeJune 20, 2023 | reuters.comINSIGHT-Lab crunch: British science has nowhere to goMay 27, 2023 | finance.yahoo.comGBLX - GB Sciences, Inc.March 20, 2023 | finance.yahoo.comGB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in ChinaMarch 7, 2023 | finance.yahoo.comSuccessful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery PlatformFebruary 18, 2023 | benzinga.comGB Sciences Stock (OTC:GBLX), Quotes and News SummaryDecember 26, 2022 | benzinga.comGb Sciences Identifies Novel Cannabis-Inspired Mixtures That Could Treat Viral InfectionsDecember 12, 2022 | finance.yahoo.comGb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based FormulationsNovember 1, 2022 | msn.comCannabis Terpenes Reduce Inflammation, Says Gb Sciences StudyNovember 1, 2022 | finance.yahoo.comGb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis IngredientsOctober 27, 2022 | finance.yahoo.comTODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic SummitOctober 24, 2022 | finance.yahoo.comGb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal StudyOctober 13, 2022 | finance.yahoo.comTODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 ConferenceOctober 10, 2022 | msn.comNew Study Shows Promising Results In Treatment Of Parkinson's Disease With CannabinoidsOctober 10, 2022 | finance.yahoo.comGb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's DiseaseSeptember 6, 2022 | finance.yahoo.comTODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal ArticleAugust 9, 2022 | ca.finance.yahoo.comGB Sciences, Inc. (GBLX)July 20, 2022 | stockhouse.comGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform-PhAROS(TM)July 19, 2022 | finance.yahoo.comGb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™July 18, 2022 | finance.yahoo.comGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™May 23, 2022 | finance.yahoo.comTODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum SummitMay 12, 2022 | stockhouse.comTODAY: Gb Sciences Showcases Its PhAROS(TM) Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform SummitMay 12, 2022 | finance.yahoo.comTODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform SummitMay 5, 2022 | finance.yahoo.comTODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics ConferenceMay 2, 2022 | finance.yahoo.comFHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory TherapiesApril 17, 2022 | msn.comGb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's DiseaseApril 12, 2022 | finance.yahoo.comGb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of LethbridgeMarch 29, 2022 | finance.yahoo.comGb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research ArticleMarch 16, 2022 | finance.yahoo.comUPDATE: Gb Sciences Issues Shareholder LetterMarch 15, 2022 | finance.yahoo.comGb Sciences Issues Summary Shareholder LetterMarch 1, 2022 | seekingalpha.comGb Sciences gets US patent for cannabinoid-containing mixture to treat heart diseaseMarch 1, 2022 | finance.yahoo.comGb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary CystitisFebruary 1, 2022 | msn.comNot So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers ClarifyFebruary 1, 2022 | finance.yahoo.comGb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus TreatmentJanuary 11, 2022 | msn.comGb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma IndustryJanuary 11, 2022 | finance.yahoo.comGb Sciences Completes $8 Million Sale of Las Vegas Cannabis FacilityDecember 6, 2021 | finance.yahoo.comGb Sciences Targets COVID-19 Treatment as Omicron Variant ArrivesNovember 1, 2021 | finance.yahoo.comGb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and AnxietySeptember 14, 2021 | finance.yahoo.comGb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related HyperinflammationSeptember 9, 2021 | finance.yahoo.comGb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment ConferenceAugust 10, 2021 | finance.yahoo.comGb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021July 27, 2021 | finance.yahoo.comGB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platform Get GB Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some GBLX Media Mentions By Week GBLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBLX News Sentiment▼0.000.43▲Average Medical News Sentiment GBLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBLX Articles This Week▼00▲GBLX Articles Average Week Get GB Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GBLX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GB Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.